Cheung et al reported that endometrial cell lines with wild-type PI3K pathway members were resistant to an mTOR inhibitor, rapamycin, suggesting that other unexamined factors, including CNA in K-Ras, might be involved in the anti-tumor effect of rapalogs [45]. The gene discussed is KRAS; the disease is neoplasm.